作者:
Kindler,H.L. [1]
;
Richards,D.A. [2]
;
Garbo,L.E. [3]
;
Garon,E.B. [4]
;
Stephenson,J.J. [5]
;
Rocha-Lima,C.M. [6]
;
Safran,H. [7]
;
Chan,D. [8]
;
Kocs,D.M. [9]
;
Galimi,F. [10]
;
Mcgreivy,J. [11]
;
Bray,S.L. [12]
;
Hei,Y. [13]
;
Feigal,E.G. ;
Loh,E. ;
Fuchs,C.S.
作者单位:
Cancer Care Associates Medical Group, Inc., Redondo Beach, United States
[1]
Global Development, Amgen Inc., Thousand Oaks, United States
[2]
Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, United
[3]
US Oncology Research, Houston, United States
[4]
Global Development, Amgen Inc., South San Francisco, United States
[5]
Department of Biostatistics and Epidemiology, Amgen Ltd, Cambridge, United Kingdom
[6]
Department of Medical Oncology/Solid Tumor Oncology, Dana-Farber Cancer Institute, Boston, United
[7]
US Oncology Research, Round Rock, United States
[8]
Department of Experimental Therapeutics, Greenville Hospital System University Medical Center
[9]
The Brown University Oncology Group, Rhode Island Hospital, Providence, United States
[10]
Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, United States
[11]
David Geffen School of Medicine, University of California Los Angeles, Translational Oncology
[12]
US Oncology Research, Tyler, United States
[13]
发布时间
2013-11-20